GREENFIELD, IN / ACCESS Newswire / February 25, 2025 / Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has ...

Elanco has struck an agreement to distribute a vaccine that may protect cattle for up to 12 months against bird flu ...

Elanco (ELAN) has entered into an agreement with South Dakota-based Medgene to leverage the company’s innovative vaccine platform technology.

Zoetis also has an H5N1 vaccine, for which it received a conditional license in 2016 and a contract award for the USDA’s ...

GREENFIELD, Ind., Feb. 25, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has entered into an agreement with South Dakota-based Medgene to leverage the ...

Elanco Animal Health inks agreement with Medgene to commercialize highly pathogenic avian influenza vaccine in dairy cattle: Greenfield, Indiana Wednesday, February 26, 2025, 15:0 ...

GREENFIELD, IN / ACCESS Newswire / February 25, 2025 / Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has entered into an agreement with South Dakota-based Medgene to leverage ...

GREENFIELD, Ind. - Elanco Animal Health (NYSE:ELAN) Incorporated (NYSE: ELAN), a $5.5 billion market cap company with annual revenues of $4.45 billion, has announced a partnership with Medgene Labs to ...

(RTTNews) - Elanco Animal Health Incorporated (ELAN) Tuesday announced a partnership with South Dakota-based Medgene to commercialize a vaccine for highly pathogenic avian influenza in dairy cattle.

Elanco Animal Health (NYSE:ELAN) stock falls as the company reports mixed Q4 2024 results, and sets 2025 outlook below consensus due to forex headwinds. Read more here.

Elanco Animal Health will commercialize an avian flu vaccine for dairy cattle after reaching an agreement with Medgene.